Summary

この調査レポートは世界の創薬アウトソーシング市場を調査し、サービスタイプ別、分子タイプ別、治療領域別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

1. レポート概要
2. エグゼクティブサマリー
3. プレミアムインサイト
4. 市場概要
5. 世界の創薬アウトソーシング市場分析：サービスタイプ別
6. 世界の創薬アウトソーシング市場分析：分子タイプ別
7. 世界の創薬アウトソーシング市場分析：治療領域別
8. 世界の創薬アウトソーシング市場分析：地域別
9. 北米の創薬アウトソーシング市場分析
10. 欧州の創薬アウトソーシング市場分析
11. アジア太平洋地域の創薬アウトソーシング市場分析
12. ラテンアメリカの創薬アウトソーシング市場分析
13. MEAの創薬アウトソーシング市場分析
14. 主要企業のプロフィール

Report Details

The Drug Discovery Outsourcing Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Outsourcing Drug Development Procedures to Benefit the Pharmaceutical Industry
Outsourcing drug development procedures allows scientists to focus on developing and commercialising new and novel methodologies and technologies, as well as other discoveries that could benefit the pharmaceutical industry. Pharmaceutical or biotech companies are looking to obtain significant added value that complements or substitutes internal power, expense, speed and development capabilities. Even small start-up drug research companies sometimes outsource their chemistry from the very beginning of their activities, because their creditors push them to do so, primarily because of cost-effectiveness reasons.

Reduced Pharmaceutical and Biotech R&D Budgets
Pharmaceutical and biotech companies now look to their outsourcing partners to weigh up important strategic and implementation decisions as well. Price, time to market, and risk are leading more businesses to reduce their innovation dependency on internal R&D. It is common practice to outsource R&D and purchase the rights to goods from smaller companies. Pharmaceutical firms are gradually entering into long-term drug development alliances with other pharmaceutical firms, universities and smaller biotech companies. Price, flexibility / scalability and exposure to new / different talent pools are the main drivers for businesses outsourcing diverse R&D functions. Companies traditionally outsourced the different functions to achieve a cost advantage, now more companies are outsourcing to get the best creativity and cooperation with their outsourcing partners. The old model was to outsource one part of the business cycle. The method was provided by outsourcers at less cost and with fair efficiency. R&D companies in life sciences today are looking at outsourcing as an innovation driver not only to bring drugs into the market quicker but also to get the information technology to make better decisions.

Advancement in Biotech Sector Driving the DDOS Market Growth
Over the last decade, a number of traditional in-house drug discovery activities have been rapidly outsourced to an increasingly competitive pharmaceutical industry that seeks to improve efficiency and reduce spending. This is due to advances in genomics and modern biotechnology, all of which have contributed to the explosion of new biological targets and new drug leads. The hit-to-candidate stage is eventually leading to a crucial bottleneck in the drug discovery process. In order to overcome this problem, the once secretive drug discovery process, such as lead identification and screening, is entrusted to drug discovery organizations specializing in areas such as chemistry services, biology services, lead optimisation as well as lead identification and screening. This push by pharmaceutical companies to gain a complete edge while remaining cost effective is the main driver drug discovery outsourcing. The main factor that the drug discovery outsourcing focuses on is the cost-saving benefits. Today’s companies are also looking at benefits and opportunities beyond cost savings. Companies are now outsourcing to obtain strategic benefits, such as access to new technologies or access to developing markets, quicker response time to help and benchmark internal initiatives, and ongoing process improvements, making them more competitive overall and growing globalization within the pharmaceutical industry.

What Are These Questions You Should Ask Before Buying A Market Research Report?
• How is the drug discovery outsourcing market evolving?
• What is driving and restraining the drug discovery outsourcing market?
• How will each Drug Discovery Outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each Drug Discovery Outsourcing submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading Drug Discovery Outsourcing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Drug Discovery Outsourcing projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What are the implication of Drug Discovery Outsourcing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery outsourcing market?
• Where is the drug discovery outsourcing market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path? C-suite?

You need to discover how this will impact the drug discovery outsourcing market today, and over the next 10 years:
• Our 355-page report provides 122 tables and 150 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analyse of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the drug discovery outsourcing market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Delivers exclusive COVID-19 variations economic data specific to your market.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Drug Discovery Outsourcing prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Segments Covered in the Report

Service Type
• Chemical Services
• Biology Services
• Lead Optimization
• Lead Identification & Screening
• Others

Molecule Type
• Large Molecule Drugs
• Small Molecule Drugs

Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
• Charles River Laboratories
• Curia Global, Inc.
• Dalton Pharma
• Domainex
• Eurofins
• Evotec AG
• Genscript
• Jubilant Biosys Ltd.
• Laboratory Corporation of America Holdings
• Pharmaron
• QIAGEN N.V.
• Selvita
• Sundia Meditech Co Ltd.
• Sygnature Discovery
• Syngene International
• Thermo Fisher Scientific Inc.
• WuXi AppTec

Overall world revenue for Drug Discovery Outsourcing Market, 2022 to 2032 in terms of value the market will surpass US$9.8 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market, 2022 to 2032 Market report helps you?
In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Drug Discovery Outsourcing Market, 2022 to 2032 Market, with forecasts for Process, upstream, downstream, type company size each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2032 for 5 regional and 20 key national markets – See forecasts for the Drug Discovery Outsourcing Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Drug Discovery Outsourcing Market, 2022 to 2032 Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Discovery Outsourcing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Premium Insights
3.1 Geographical Snapshot: Global Drug Discovery Outsourcing Market
3.2 Service Type Segment: Market Attractiveness Index
3.3 Molecule Type Segment: Market Attractiveness Index
3.4 Therapeutic Area Segment: Market Attractiveness Index

4 Market Overview
4.1 Market Dynamics
4.1.1 Market Driving Factors
4.1.2 Market Restraining Factors
4.1.3 Market Opportunities
4.2 COVID-19 Impact Analysis
4.3 R&D Outsourcing Business Model (Fee-for-Service)
4.4 Collaborations Between CRO and Pharmaceutical Industry
4.5 Porter’s Five Forces Analysis
4.5.1 Competitive Rivalry: High
4.5.2 Threat of Substitutes: Medium
4.5.3 Bargaining Power of Buyer: High
4.5.4 Bargaining Power of Suppliers: Medium
4.5.5 Threat of New Entrants: Medium

5 Global Drug Discovery Outsourcing Market Analysis by Service Type
5.1 Key Findings
5.2 Service Type Segment Growth Prospects
5.3 Global Drug Discovery Outsourcing Market Size Estimation and Forecast by Service Type
5.4 Chemical Services
5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 Biology Services
5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Market Share by Region, 2022 & 2032 (%)
5.6 Lead Optimization
5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 Market Share by Region, 2022 & 2032 (%)
5.7 Lead Identification & Screening
5.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Market Share by Region, 2022 & 2032 (%)
5.8 Others
5.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
5.8.2 Market Share by Region, 2022 & 2032 (%)

6 Global Drug Discovery Outsourcing Market Analysis by Molecule Type
6.1 Key Findings
6.2 Molecule Type Segment Growth Prospects
6.3 Global Drug Discovery Outsourcing Market Size Estimation and Forecast by Molecule Type
6.4 Large Molecule Drugs
6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.4.3 Market Forecast by Type, 2022-2032 (US$ Mn)
6.5 Small Molecule Drugs
6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Market Share by Region, 2022 & 2032 (%)

7 Global Drug Discovery Outsourcing Market Analysis by Therapeutic Area
7.1 Key Findings
7.2 Therapeutic Area Segment Growth Prospects
7.3 Global Drug Discovery Outsourcing Market Size Estimation and Forecast by Therapeutic Area
7.4 Oncology
7.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Infectious Disease
7.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Central Nervous System
7.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Immunology
7.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Cardiovascular Disease
7.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Metabolic Disease
7.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.9.2 Market Share by Region, 2022 & 2032 (%)
7.10 Respiratory Disease
7.10.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.10.2 Market Share by Region, 2022 & 2032 (%)
7.11 Others
7.11.1 Market Forecast by Region, 2022-2032 (US$ Mn)
7.11.2 Market Share by Region, 2022 & 2032 (%)

8 Global Drug Discovery Outsourcing Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

9 North America Drug Discovery Outsourcing Market Analysis
9.1 Key Findings
9.2 North America Drug Discovery Outsourcing Market Attractiveness Index
9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
9.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
9.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
9.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
9.8 U.S.
9.9 Canada

10 Europe Drug Discovery Outsourcing Market Analysis
10.1 Key Findings
10.2 Europe Drug Discovery Outsourcing Market Attractiveness Index
10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
10.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
10.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
10.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
10.8 Germany
10.9 UK
10.10 France
10.11 Italy
10.12 Spain
10.13 Russia
10.14 Rest of Europe

11 Asia Pacific Drug Discovery Outsourcing Market Analysis
11.1 Key Findings
11.2 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
11.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
11.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
11.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
11.8 Japan
11.9 China
11.10 India
11.11 Australia
11.12 South Korea
11.13 Rest of Asia Pacific

12 Latin America Drug Discovery Outsourcing Market Analysis
12.1 Key Findings
12.2 Latin America Drug Discovery Outsourcing Market Attractiveness Index
12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
12.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
12.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
12.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
12.8 Brazil
12.9 Mexico
12.10 Rest of Latin America

13 MEA Drug Discovery Outsourcing Market Analysis
13.1 Key Findings
13.2 MEA Drug Discovery Outsourcing Market Attractiveness Index
13.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
13.5 Market Size Estimation and Forecast by Service Type, 2022-2032 (US$ Mn)
13.6 Market Size Estimation and Forecast by Molecule Type, 2022-2032 (US$ Mn)
13.7 Market Size Estimation and Forecast by Therapeutic Area, 2022-2032 (US$ Mn)
13.8 GCC
13.9 South Africa
13.10 Rest of MEA

14 Company Profiles
14.1 Curia Global, Inc.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Product Benchmarking
14.2 Charles River Laboratories
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.4 Product Benchmarking
14.2.5 Strategic Outlook
14.3 Dalton Pharma
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Product Benchmarking
14.3.4 Strategic Outlook
14.4 Domainex
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Product Benchmarking
14.4.4 Strategic Outlook
14.5 Eurofins
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.4 Product Benchmarking
14.5.5 Strategic Outlook
14.6 Evotec AG
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.4 Product Benchmarking
14.6.5 Strategic Outlook
14.7 Genscript
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Jubilant Biosys Ltd.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Laboratory Corporation of America Holdings
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Pharmaron
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 QIAGEN N.V.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Selvita
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Sundia Meditech Co Ltd.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Sygnature Discovery
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Product Benchmarking
14.15.4 Strategic Outlook
14.16 Syngene International
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Thermo Fisher Scientific Inc.
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.4 Product Benchmarking
14.17.5 Strategic Outlook
14.18 WuXi AppTec
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Global Drug Discovery Outsourcing Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 Global Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 7 Chemical Services Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 8 Biology Services Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 9 Lead Optimization Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 10 Lead Identification & Screening Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 11 Others Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 12 Global Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 13 Large Molecule Drugs Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 14 Large Molecule Drugs Market Forecast by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 15 Small Molecule Drugs Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 16 Global Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 17 Oncology Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 18 Infectious Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 19 Central Nervous System Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 20 Immunology Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 21 Cardiovascular Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 22 Metabolic Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 23 Respiratory Disease Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 24 Others Segment Market Forecast by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 25 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 26 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 27 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 28 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 29 Global Drug Discovery Outsourcing Market Forecast by Region 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 30 North America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 31 North America Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 32 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 33 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 34 U.S. Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 35 Canada Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 36 Europe Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 37 Europe Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 38 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 39 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 40 Germany Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 41 UK Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 42 France Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 43 Italy Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 44 Spain Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 45 Russia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 46 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 47 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 48 Asia Pacific Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 49 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 50 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 51 Japan Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 52 China Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 53 India Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 54 Australia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 55 South Korea Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 56 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 57 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 58 Latin America Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 59 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 60 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 61 Brazil Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 62 Mexico Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 63 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 64 MEA Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 65 MEA Drug Discovery Outsourcing Market Forecast by Services, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 66 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 67 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 68 GCC Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 69 South Africa Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 70 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%)
Table 71 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Curia Global, Inc.: Product Benchmarking
Table 73 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Charles River Laboratories: Product Benchmarking
Table 75 Charles River Laboratories: Strategic Outlook
Table 76 Dalton Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Dalton Pharma: Product Benchmarking
Table 78 Dalton Pharma: Strategic Outlook
Table 79 Domainex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Domainex: Product Benchmarking
Table 81 Domainex: Strategic Outlook
Table 82 Eurofins: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Eurofins: Product Benchmarking
Table 84 Eurofins: Strategic Outlook
Table 85 Evotec AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Evotec AG: Product Benchmarking
Table 87 Evotec AG: Strategic Outlook
Table 88 Genscript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Genscript: Product Benchmarking
Table 90 Genscript: Strategic Outlook
Table 91 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Product Benchmarking
Table 93 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Strategic Outlook
Table 94 Jubilant Biosys Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Jubilant Biosys Ltd.: Product Benchmarking
Table 96 Jubilant Biosys Ltd.: Strategic Outlook
Table 97 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Laboratory Corporation of America Holdings: Product Benchmarking
Table 99 Laboratory Corporation of America Holdings: Strategic Outlook
Table 100 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Pharmaron: Product Benchmarking
Table 102 Pharmaron: Strategic Outlook
Table 103 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 QIAGEN N.V.: Product Benchmarking
Table 105 QIAGEN N.V.: Strategic Outlook
Table 106 Selvita: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Selvita: Product Benchmarking
Table 108 Selvita: Strategic Outlook
Table 109 Sundia Meditech Co Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Sundia Meditech Co Ltd.: Product Benchmarking
Table 111 Sygnature Discovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Sygnature Discovery: Product Benchmarking
Table 113 Sygnature Discovery: Strategic Outlook
Table 114 Syngene International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Syngene International: Product Benchmarking
Table 116 Syngene International: Strategic Outlook
Table 117 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 119 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 120 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 WuXi AppTec: Product Benchmarking
Table 122 WuXi AppTec: Strategic Outlook
 
List of Figures
Figure 1 Global Drug Discovery Outsourcing Market Segmentation
Figure 2 Global Drug Discovery Outsourcing Market Attractiveness Index by Region
Figure 3 Global Drug Discovery Outsourcing Market by Service Type: Market Attractiveness Index
Figure 4 Global Drug Discovery Outsourcing Market by Molecule Type: Market Attractiveness Index
Figure 5 Global Drug Discovery Outsourcing Market by Therapeutic Area: Market Attractiveness Index
Figure 6 Global Drug Discovery Outsourcing Market: Market Dynamics
Figure 7 Global COVID Impact Analysis: Drug Discovery Outsourcing Market Recovery Scenarios
Figure 8 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Global Drug Discovery Outsourcing Market: Porter’s Five Forces Analysis
Figure 13 Global Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 14 Global Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 15 Global Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022, 2027, 2032 (%)
Figure 16 Chemical Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 17 Chemical Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 18 Biology Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 19 Biology Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 20 Lead Optimization Market Forecast by Region, 2022-2032 (US$ million)
Figure 21 Lead Optimization Market Share Forecast by Region, 2022 & 2032 (%)
Figure 22 Lead Identification & Screening Market Forecast by Region, 2022-2032 (US$ million)
Figure 23 Lead Identification & Screening Market Share Forecast by Region, 2022 & 2032 (%)
Figure 24 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 Global Drug Discovery Outsourcing Market Attractiveness Index by Molecule Type
Figure 27 Global Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 28 Global Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022, 2027, 2032 (%)
Figure 29 Large Molecule Drugs Market Forecast by Region, 2022-2032 (US$ million)
Figure 30 Large Molecule Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 31 Large Molecule Drugs Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Small Molecule Drugs Market Forecast by Region, 2022-2032 (US$ million)
Figure 33 Small Molecule Drugs Market Share Forecast by Region, 2022 & 2032 (%)
Figure 34 Global Drug Discovery Outsourcing Market Attractiveness Index by Therapeutic Area
Figure 35 Global Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 36 Global Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022, 2027, 2032 (%)
Figure 37 Oncology Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Oncology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Infectious Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Infectious Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Central Nervous System Market Forecast by Region, 2022-2032 (US$ million)
Figure 42 Central Nervous System Market Share Forecast by Region, 2022 & 2032 (%)
Figure 43 Immunology Market Forecast by Region, 2022-2032 (US$ million)
Figure 44 Immunology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 45 Cardiovascular Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 46 Cardiovascular Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 47 Metabolic Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 48 Metabolic Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 49 Respiratory Disease Market Forecast by Region, 2022-2032 (US$ million)
Figure 50 Respiratory Disease Market Share Forecast by Region, 2022 & 2032 (%)
Figure 51 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 52 Others Market Share Forecast by Region, 2022 & 2032 (%)
Figure 53 Global Drug Discovery Outsourcing Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 54 Global Drug Discovery Outsourcing Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 55 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%))
Figure 56 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 57 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 58 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 59 Global Drug Discovery Outsourcing Market by Region, 2022-2032 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 60 North America Drug Discovery Outsourcing Market Attractiveness Index
Figure 61 North America Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 62 North America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 63 North America Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 64 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 65 North America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 66 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 67 North America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 68 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 69 North America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 70 U.S. Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 71 Canada Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 72 Europe Drug Discovery Outsourcing Market Attractiveness Index
Figure 73 Europe Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 74 Europe Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 75 Europe Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 76 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 77 Europe Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 78 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 79 Europe Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 80 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 81 Europe Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 82 Germany Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 83 UK Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 84 France Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 85 Italy Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 86 Spain Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 87 Russia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 88 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 89 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
Figure 90 Asia Pacific Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 91 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 92 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 93 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 94 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 95 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 96 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 97 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 98 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 99 Japan Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 100 China Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 101 India Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 102 Australia Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 103 South Korea Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 104 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 105 Latin America Drug Discovery Outsourcing Market Attractiveness Index
Figure 106 Latin America Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 107 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 108 Latin America Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 109 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 110 Latin America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 111 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 112 Latin America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 113 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 114 Latin America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 115 Brazil Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 116 Mexico Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 117 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 118 MEA Drug Discovery Outsourcing Market Attractiveness Index
Figure 119 MEA Drug Discovery Outsourcing Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 120 MEA Drug Discovery Outsourcing Market Forecast by Country, 2022-2032 (US$ million)
Figure 121 MEA Drug Discovery Outsourcing Market Share Forecast by Country, 2022 & 2032 (%)
Figure 122 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2022-2032 (US$ million)
Figure 123 MEA Drug Discovery Outsourcing Market Share Forecast by Service Type, 2022 & 2032 (%)
Figure 124 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2022-2032 (US$ million)
Figure 125 MEA Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2022 & 2032 (%)
Figure 126 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2022-2032 (US$ million)
Figure 127 MEA Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2022 & 2032 (%)
Figure 128 GCC Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 129 South Africa Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 130 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2022-2032 (US$ million)
Figure 131 Charles River Laboratories: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 132 Charles River Laboratories: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 133 Eurofins: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 134 Eurofins: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 135 Evotec AG: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 136 Evotec AG: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 137 Evotec AG: R&D, 2015-2021 (US$ million, AGR%)
Figure 138 Genscript: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 139 Jubilant Biosys Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 140 Laboratory Corporation of America Holdings: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 141 Laboratory Corporation of America Holdings: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 142 Pharmaron: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 143 QIAGEN N.V.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 144 QIAGEN N.V.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 145 QIAGEN N.V.: R&D, 2015-2021 (US$ million, AGR%)
Figure 146 Syngene International: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 147 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 148 Thermo Fisher Scientific Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 149 Thermo Fisher Scientific Inc.: R&D, 2015-2021 (US$ million, AGR%)
Figure 150 WuXi AppTec: Net Revenue, 2015-2021 (US$ million, AGR%)